I have to agree, although i'm biased cause i hold.
But yes the Ventrasist will be in a few years the best product of choice available on the market.
The question is this though, will acceptance of LVAD's be strong enough to support a one product company like VCR.
The medical profession will be the one's who decide that.
As for the share price...we all know it stinks, what more can be said.
- Forums
- ASX - By Stock
- vcrs removal from asx 300 and the asx sp ind
VCR
ventracor limited
I have to agree, although i'm biased cause i hold.But yes the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online